Nintedanib Esylate

1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate

2.1.2 InChI

InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-

2.1.3 InChI Key

XZXHXSATPCNXJR-ZIADKAODSA-N

2.1.4 Canonical SMILES

CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5

2.1.5 Isomeric SMILES

CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N/C(=C\3/C4=C(C=C(C=C4)C(=O)OC)NC3=O)/C5=CC=CC=C5

2.2 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₃₁H₃₃N₅O₄
Molecular Weight	539.6 g/mol
XLogP3	3.3
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	8
Exact Mass	539.25325455 g/mol
Monoisotopic Mass	539.25325455 g/mol
Topological Polar Surface Area	94.2 A^2
Heavy Atom Count	40
Formal Charge	0
Complexity	947
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Ofev
Drug Label	OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action (12.1)]. Nintedanib is presented as the ethanesulfonate salt (esylate), with the chemical name 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazin...
Active Ingredient	Nintedanib
Dosage Form	Capsule
Route	Oral
Strength	150mg; 100mg
Market Status	Prescription
Company	Boehringer Ingelheim

2 of 2
Drug Name	Ofev
Drug Label	OFEV capsules contain nintedanib, a kinase inhibitor [see Mechanism of Action (12.1)]. Nintedanib is presented as the ethanesulfonate salt (esylate), with the chemical name 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[(4-methyl-1-piperazin...
Active Ingredient	Nintedanib
Dosage Form	Capsule
Route	Oral
Strength	150mg; 100mg
Market Status	Prescription
Company	Boehringer Ingelheim

Technical details about Nintedanib Esylate, learn more about the structure, uses, toxicity, action, side effects and more

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

42 Suppliers

17 USDMF

5 EU WC

6 KDMF

12 NDC API

30 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

INTERMEDIATES

16 Suppliers

DOSSIERs // Finished Dosage Forms

35 Dossiers

8 FDA Orange Book

15 Europe

2 Canada

4 Australia

2 South Africa

4 Listed Dossiers

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions

9 Finished Drug Prices

MARKET PLACE

4 APIs

5 DOSSIERS // FDF

PATENTS

18 US Patents

4 US Exclusivities

REF. STANDARDS & IMPURITIES

1 Others

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow

67 News

Nintedanib Esylate